BJU Int
- LEWICKI P, Ginsburg K, Mmonu N, Labardee C, et al 
 What is lost in an average? Identifying distinct post-radical prostatectomy 
functional recovery profiles.
 BJU Int. 2025;136:633-639.
 
 
- ZAURITO P, Westerberg M, Garmo H, Gedeborg R, et al 
 Urinary tract events after radical radiotherapy (RT) for prostate cancer 
according to pre-RT International Prostate Symptom Score.
 BJU Int. 2025 Sep 12. doi: 10.1111/bju.16927.
 
 
- BYRNE MHV, Anbarasan T, Browning L, Woodcock DJ, et al 
 What spatial omics is teaching us about field cancerisation in prostate and 
bladder cancer.
 BJU Int. 2025 Jun 25. doi: 10.1111/bju.16830.
 
 
- HALL R, Ball R, Bancroft E, Eeles R, et al 
 Systematic review of PSA reference intervals in the gender diverse population 
with prostates.
 BJU Int. 2025;136:568-577.
 
 
- VISSCHER J, Bonevski B, O'Callaghan M 
 The association of smoking with urinary and sexual function recovery following 
radical prostatectomy.
 BJU Int. 2025;136:647-656.
 
 
 BMC Urol
 
 
- INOUE K, Shinohara M, Saka T, Hirao Y, et al 
 Correction: Evaluation of the changes in hydrogel spacer volume in patients 
treated with proton therapy for prostate cancer.
 BMC Urol. 2025;25:228.
 
 
 Clin Cancer Res
 
 
- BLINKA S, Yu EY 
 Drug targets in prostate cancer: an appetite for KLK2-mediated destruction.
 Clin Cancer Res. 2025 Sep 9. doi: 10.1158/1078-0432.CCR-25-2546.
 
 
 Eur Radiol
 
 
- GIROMETTI R, Peruzzi V, Clauser P, Potsch N, et al 
 Diffusion levels for quantitative assessment of the apparent diffusion 
coefficient value in prostate MRI: a proof-of-concept bicentric study.
 Eur Radiol. 2025;35:6171-6182.
 
 
 Eur Urol
 
 
- LI S, Wang C 
 Re: Sarah Burdett, David J Fisher, Jayne F. Tierney, et al. Duration of Androgen 
Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate 
Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data. 
Eur Urol.
 Eur Urol. 2025 Sep 6:S0302-2838(25)00480-4. doi: 10.1016/j.eururo.2025.
 
 
- LI J, Zhang Y, Hu H 
 Re: Metformin for Patients with Metastatic Prostate Cancer Starting Androgen 
Deprivation Therapy: A Randomised Phase 3 Trial of the STAMPEDE Platform 
Protocol.
 Eur Urol. 2025 Sep 8:S0302-2838(25)00483-X. doi: 10.1016/j.eururo.2025.
 
 
- DU Y, Liu D, Guan Z 
 Re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance 
Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results 
from a Large Cohort Study. Eur Urol. In press. 
https://doi.org/10.1016/j.eururo.2025.03.0
 Eur Urol. 2025 Sep 9:S0302-2838(25)00478-6. doi: 10.1016/j.eururo.2025.
 
 
 Int J Cancer
 
 
- LIN E, Garmo H, Beckmann K, Bratt O, et al 
 Prostate cancer characteristics in fathers and risk of early onset high-risk 
prostate cancer in sons.
 Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70133.
 
 
 Int J Radiat Oncol Biol Phys
 
 
- TISSEVERASINGHE S, Niazi T 
 Pelvic Nodal Irradiation Should Be Offered to High-Risk Prostate Cancer Patients 
Receiving Radiation Therapy.
 Int J Radiat Oncol Biol Phys. 2025;123:387-391.
 
 
- ACHARD V, Benziane-Ouaritini N, Sargos P 
 Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative 
Setting: Is It Capable of Going the Distance?
 Int J Radiat Oncol Biol Phys. 2025;123:381-383.
 
 
- RAMADAN S, Loblaw A, Dhar A, Fakir H, et al 
 PSMA MRI Guided prOstate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of 
IMaging BiomarkErs Post Radiotherapy (CLIMBER) Phase I/II Trial.
 Int J Radiat Oncol Biol Phys. 2025;123:395-405.
 
 
- RANTA K, Wojcieszynski AP, Zhao SG, Liu Y, et al 
 Severe Late Toxicities (Grade 3-5) With 13 Years of Follow-up after 
Hypofractionated Postprostatectomy Radiotherapy.
 Int J Radiat Oncol Biol Phys. 2025;123:374-380.
 
 
- SAAD E, Hoskin P, Choudhury A 
 Prophylactic Pelvic Nodal Radiation Therapy in High-risk Node-negative Prostate 
Cancer: The Case Against.
 Int J Radiat Oncol Biol Phys. 2025;123:392-394.
 
 
 J Nucl Med
 
 
- BEINTNER-SKAWRAN S, Gafita A, Lorenzini T, Tauber R, et al 
 [(68)Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with 
Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy.
 J Nucl Med. 2025 Sep 11:jnumed.125.269584. doi: 10.2967/jnumed.125.269584.
 
 
 J Urol
 
 
- DASKIVICH TJ, Stock SR, Cummings S, Masterson JM, et al 
 Risks of Progression After Early Androgen Deprivation Therapy for Biochemical 
Recurrence After Radical Prostatectomy.
 J Urol. 2025;214:354-364.
 
 
- FREITAS PFS, Khandekar A, Porto JG, Yu H, et al 
 Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict 
Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective 
Miami Active Surveillance Trial.
 J Urol. 2025;214:383-392.
 
 
 JAMA
 
 
- NG ABCD, Asif A, Agarwal R, Panebianco V, et al 
 Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME 
Diagnostic Clinical Trial.
 JAMA. 2025 Sep 10:e2513722. doi: 10.1001/jama.2025.13722.
 
 
 PLoS One
 
 
- BACH CA, Hossain MN, Chaudhari IJ, Verrillo CE, et al 
 A novel sialylation pathway mediated by extracellular vesicles in aggressive 
prostate cancer.
 PLoS One. 2025;20:e0329014.
 
 
 Prostate
 
 
- HUNT TC, Malshy K, Steidle M, Li A, et al 
 Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized 
Prostate Cancer.
 Prostate. 2025 Sep 9. doi: 10.1002/pros.70043.
 
 
- FALKENBACH F, Di Bello F, Penaranda NR, Longoni M, et al 
 USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific 
Mortality in Localized Prostate Cancer.
 Prostate. 2025 Sep 9. doi: 10.1002/pros.70045.
 
 
 Radiol Artif Intell
 
 
- MORADI A, Zerka F, Bosma JS, Sunoqrot MRS, et al 
 Optimizing Federated Learning Configurations for MRI Prostate Segmentation and 
Cancer Detection: A Simulation Study.
 Radiol Artif Intell. 2025 Jul 30:e240485. doi: 10.1148/ryai.240485.
 
 
 Urology
 
 
- MARTIN C, Maoate K, Hooshyari A, Ordones FV, et al 
 Transitioning to Office-based Transperineal Prostate Biopsy-A Case Study From a 
Regional New Zealand Hospital in Economic and Environmental Sustainability.
 Urology. 2025;203:53-59.
 
 
 
Free Medical Abstracts
 Privacy Policy
Privacy Policy
 Sponsors
Sponsors
 Share
Share
© Amedeo 1997-2016